Terug
Dagbereik
€ 34,05
€ 35,14
52-Weeksbereik
€ 3,72
€ 43,73
Volume
1.849.362
50D / 200D Gem.
€ 37,17
/
€ 23,42
Vorige Slotkoers
€ 35,41
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | -17,3 | 0,3 |
| P/B | 8,9 | 2,9 |
| ROE % | -73,7 | 3,7 |
| Net Margin % | — | 3,8 |
| Rev Growth 5Y % | — | 10,0 |
| D/E | 0,4 | 0,2 |
Koersdoel Analisten
Hold
€ 48,13
+37.7%
Low: € 35,00
High: € 60,00
Forward WPA
-€ 2,14
Omzet Sch.
18 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 4,76
€ 0,57 – € 12,01
|
1,7 B | 6 |
| FY2029 |
€ 3,07
€ 0,37 – € 7,75
|
1,3 B | 6 |
| FY2028 |
€ 1,05
€ 0,23 – € 2,35
|
760 M | 8 |
Belangrijkste Punten
Debt/Equity of 0,40 — conservative balance sheet
Negative free cash flow of -266,00M
Groei
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
-73,70%
ROIC-28,11%
Net MarginN/A
Op. MarginN/A
Veiligheid
Debt / Equity
0,40
Current Ratio14,23
Interest Coverage-108,87
Waardering
P/E Ratio
-17,25
P/B Ratio8,92
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0,0 | Net Income (TTM) | -328,94M |
| ROE | -73,70% | ROA | -35,08% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -266,00M |
| ROIC | -28,11% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0,40 | Current Ratio | 14,23 |
| Interest Coverage | -108,87 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -17,25 | P/B Ratio | 8,92 |
| P/S Ratio | N/A | PEG Ratio | -2,00 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 5,67B | Enterprise Value | 5,62B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0,0 | 0,0 | 0,0 | 0,0 | 0,0 |
| Net Income | -328,94M | -255,86M | -192,41M | -140,24M | -72,27M |
| EPS (Diluted) | -2,55 | -2,46 | -2,42 | -2,26 | -1,85 |
| Gross Profit | -4,62M | 0,0 | 0,0 | 0,0 | 0,0 |
| Operating Income | -333,36M | -275,94M | -208,13M | -147,84M | -75,55M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 937,61M | 327,90M | 313,44M | 300,81M | 232,09M |
| Total Liabilities | 301,24M | 71,61M | 55,64M | 45,08M | 17,91M |
| Shareholders' Equity | 636,37M | 256,29M | 257,80M | 255,74M | 214,18M |
| Total Debt | 253,15M | 17,47M | 18,85M | 19,65M | 3,16M |
| Cash & Equivalents | 312,01M | 98,17M | 53,23M | 139,89M | 219,68M |
| Current Assets | 910,36M | 296,47M | 270,77M | 264,97M | 222,63M |
| Current Liabilities | 63,95M | 55,71M | 38,17M | 26,85M | 17,08M |